Lipid homeostasis and oxidative stress in the liver of male rats exposed to perfluorododecanoic acid

Toxicology and Applied Pharmacology

Volumn 227, Issue 1, 2008, Pages 16-25

  Zhang, Hongxia ^a,b   Shi, Zhimin ^a   Liu, Yang ^a   Wei, Yanhong ^a   Dai, Jiayin ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Hepatotoxicity; LXR ; Male rats; Oxidative stress; PFDoA; PPAR

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CATALASE; CHOLESTEROL 7ALPHA MONOOXYGENASE; DECANOIC ACID DERIVATIVE; LIVER X RECEPTOR ALPHA; PERFLUORODODECANOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPOSURE; GENE EXPRESSION; HISTOPATHOLOGY; HOMEOSTASIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID PEROXIDATION; LIVER; LIVER TOXICITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POLLUTANT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BASE SEQUENCE; CATALASE; DNA PRIMERS; HOMEOSTASIS; LAURIC ACIDS; LIPID METABOLISM; LIPID PEROXIDATION; LIVER; MALE; MICROSCOPY, ELECTRON; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE;

ANIMALIA; RATTUS;

EID: 38749120620     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.09.026     Document Type: Article

References (58)

1. Berger J., and Moller D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 53 (2002) 409-435
2. Biegel L.B., Hurrt M.E., Frame S.R., O'Connor J.C., and Cook J.C. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol. Sci. 60 (2001) 44-55
3. Ehresman D.J., Chang S., Bjork J.A., Hart J.A., Lieder P.H., Wallace K.B., and Butenhoff J.L. Increased acyl CoA oxidase activity in rats after five consecutive daily doses of perfluorobutanesulfonate, perfluorohexanesulfonate, and perfluorooctanesulfonate. Toxicologist 96 (2007) 179 (Abstract)
4. Elcombe, C.R., Wolf, C.R., 2004. Perfluorinated fatty acids for the treatment of diabetes, obesity, cardiovascular disease or as anti-tumour agents. UK Patent GB 2392386.
5. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53 Suppl 1 (2004) S43-S50
6. Gavrilova O., Haluzik M., Matsusue K., Cutson J.J., Johnson L., Dietz K.R., Nicol C.J., Vinson C., Gonzalez F.J., and Reitman M.L. Liver peroxisome proliferators-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem. 278 (2003) 34268-34276
7. Giesy J.P., and Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ. Sci. Technol. 35 (2001) 1339-1342
8. Guruge K.S., Yeung L.W.Y., Yamanaka N., Miyazaki S., Lam P.K.S., Giesy J.P., Jones P.D., and Yamashita N. Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA). Toxicol. Sci. 89 (2006) 93-107
9. Haughom B., and Spydevold O. The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid. Biochim. Biophys. Acta 11128 (1992) 65-72
10. Hihi A.K., Michalik L., and Wahli W. PPARs: transcriptional effectors of fatty acids and their derivatives. Cell Mol. Life Sci. 59 (2002) 790-798
11. Hoepfner D., Schildknegt D., Braakman I., Philippsen P., and Tabak H.F. Contribution of the endoplasmic reticulum to peroxisome formation. Cell 122 (2005) 85-95
12. Hundley S.G., Sarrif A.M., and Kennedy G.L. Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. Drug Chem. Toxicol. 29 (2006) 137-145
13. Iida K.T., Kawakami Y., Suzuki H., Sone H., Shimano H., Toyoshima H., Okuda Y., and Yamada N. PPARQ ligands, troglitazone and pioglitazone, upregulate expression of HMG-CoA synthase and HMG-CoA reductase gene in THP-1 macrophages. FEBS Lett. 520 (2002) 177-181
14. Intrasuksri U., Rangwala S.M., O'Brien M., Noonan D.J., and Feller D.R. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids. Gen. Pharmacol. 31 (1998) 187-197
15. Kannan K., Choi J.W., Iseki N., Senthikumar K., Kim D.H., and Giesy J.P. Concentration of perfluorinated acids in livers of birds from Japan and Korea. Chemosphere 49 (2002) 225-231
16. Kannan K., Corsolini S., Falandysz J., Oehme G., Focardi S., and Giesy J.P. Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes and birds from coasts of the Baltic and the Mediterranean Seas. Environ. Sci. Technol. 36 (2002) 3120-3126
17. Kawashima Y., Uy-Yu N., and Kozuka H. Sex-related differences in the enhancing effects of perfluoro-octanoic acid on stearoyl-CoA desaturase and its influence on the acyl composition of phospholipid in rat liver. Comparison with clofibric acid and tiadenol. Biochem. J. 263 (1989) 897-940
18. Kenney Jr. G.L. Increase in mouse liver weight following feeding of a ammonium perfluorooctanoate and related fluorochemical. Toxicol. Lett. 39 (1987) 295-300
19. Kenney Jr. G.L., Butenhoff J.L., Olsen G.W., O'Connor J.C., Seacat A.M., Perkins R.G., Biegel B.L., Murphy S.R., and Farrar D.G. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 34 (2004) 351-384
20. Kono Y., and Fridovich I. Superoxide radicals inhibit catalase. J. Biol. Chem. 257 (1982) 5751-5754
21. Kudo N., Mizuguchi H., Yamamoto A., and Kawashima Y. Alterations by perfluorooctanoic acid of glycerolipid metabolism in rat liver. Chem. Biol. Interact. 118 (1999) 69-83
22. Kudo N., Bandi N., Suzuki E., Katakura M., and Kawashima Y. Induction by perfluorinated fatty acids with different carbon chain length of peroxisomal β-oxidation in the liver of rats. Chem. Biol. Interact. 124 (2000) 119-132
23. Kudo N., Suzuki E., Katakura M., Ohmori K., Noshiro R., and Kawashima Y. Comparison of the elimination between perfluorinated fatty acids with different carbon chain length in rats. Chem. Biol. Interact. 134 (2001) 203-216
24. Kudo N., Suzuki-Nakajima E., Mitsumoto A., and Kawashima Y. Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice: in relation to induction of hepatomegaly, peroxisomal β-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase. Biol. Pharm. Bull. 29 (2006) 1952-1957
25. Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., Seed, J., in press. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci.
26. Lavoie J.M., and Gauthier M.S. Regulation of fat metabolism in the liver: link to nonalcoholic hepatic steatosis and impact of physical exercise. Cell. Mol. Life Sci. 63 (2006) 1393-1409
27. Liu C., Ke Y., Shi X., Wang J., Lam P.K.S., Wu R.S.S., and Zhou B. Induction of oxidative stress and apoptosis by PFOS and PFOA in primary cultured hepatocytes of freshwater tilapia (Oreochromis niloticus). Aquat. Toxicol. 82 (2007) 135-143
28. Loveless S.E., Finlay C., Everds N.E., Frame S.R., Gillies P.J., O'Connor J.C., Powley C.R., and Kennedy G.L. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicol. 220 (2006) 203-217
29. Maloney E.K., and Waxman D.J. Trans-activation of PPARα and PPARγ by structurally diverse environmental chemicals. Toxicol. Appl. Pharmacol. 161 (1999) 209-218
30. Martin J.W., Smithwick M.M., Braune B.M., Hoekstra P.F., Muir D.C., and Mabury S.A. Identification of long-chain perfluorinated acids in biota from the Canadian Arctic. Environ. Sci. Technol. 38 (2004) 373-380
31. Martin M.T., Brennan R.J., Hu W., Ayanoglu E., Lau C., Ren H., Wood C.R., Corton C., Kaclock R.J., and Dix D.J. Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity. Toxicol. Sci. 97 (2007) 95-613
32. Miserez A.R., Cao G., Probst L.C., and Hobbs H.H. Structure of the human gene encoding sterol regulatory element binding protein 2 (SREBP2). Genomics 40 (1997) 31-40
33. Moody C.A., Martin J.W., Kwan W.C., Muir D.G., and Mabury S.A. Monitoring perfluorinated surfactants in biota and surface water samples following an accidental release of fire-fighting foam into Etobicoke Creek. Environ. Sci. Technol. 36 (2002) 545-551
34. Ohmori K., Kudo N., Katayama K., and Kawashima Y. Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 184 (2003) 135-140
35. Okochi E., Nishimaki-Mogami T., Suzuki K., and Takahashi A. Perfluorooctanoid acid, a peroxisome-proliferating hypolipidemic agent, dissociates apolipoprotein B48 from lipoprotein particles and decrease secretion of very low density lipoproteins by cultured rat hepatocytes. Biochim. Biophys. Acta 1437 (1999) 393-401
36. Olson C.T., and Andersen M.E. The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids. Toxicol. Appl. Pharmacol. 70 (1983) 362-372
37. Ou J., Tu H., Shan B., Luk A., DeBose-Boyd R.A., Bashmakov Y., Goldstein J.L., and Brown M.S. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6027-6032
38. Panaretakis T., Shabalina I.G., Grand'er D., Shoshan M.C., and DePierre J.W. Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 Cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. Toxicol. Appl. Pharmacol. 173 (2001) 56-64
39. Pawar A., Xu J., Jerks E., Mangelsdorf D.J., and Jump D.B. Fatty acid regulation of liver X receptors (LXR) and peroxisome proliferator-activated receptor alpha (PPARalpha) in HEK293 cells. J. Biol. Chem. 277 (2002) 39243-39250
40. Pawar A., Botolin D., Mangelsdorf D.J., and Jump D.B. The role of liver X receptor-α in the fatty acid regulation of hepatic gene expression. J. Biol. Chem. 278 (2003) 40736-40743
41. Perkins R.G. Investigation of ammonium perfluorooctanoate effect on hormone levels and peroxisomal proliferation in the rat. Toxicologist 12 (1992) 52
42. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) 2002-2007
43. Russell D.W. Nuclear orphan receptors control cholesterol catabolism. Cell 97 (1999) 539-542
44. Schadinger S.E., Bucher N.L.R., Schreiber B.M., and Farmer S.R. PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E1195-E1205
45. Schultz J.R., Tu H., Luk A., Repa J.J., Medina J.C., Li L., Schwendner S., Wang S., Thoolen M., Mangelsdorf D.J., Lustig K.D., and Shan B. Role of LXRs in control of lipogenesis. Genes Dev. 14 (2000) 2831-2838
46. Seacat A.M., Thomford P.J., Hansen K.J., Olsen G.W., Case M.T., and Butenhoff J.L. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 68 (2002) 249-264
47. Seacat A.M., Thomford P.J., Hansen K.J., Clemen L.A., Eldridge S.R., Elcombe C.R., and Butenhoff J.L. Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicol. 183 (2003) 117-131
48. Shearer B.G., and Hoekstra W.J. Recent advances in peroxisome proliferator-activated receptor science. Curr. Med. Chem. 10 (2003) 267-280
49. Shi Z., Zhang H., Liu Y., Xu M., and Dai J. Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid. Toxicol. Sci. 98 (2007) 206-215
50. Shimano H., Yahagi N., Amemiya-Kudo M., Hasty A.H., Osuga J., Tamura Y., Shionoiri F., Iizuka Y., Ohashi K., Harada K., Gotoda T., Ishibashi S., and Yamada N. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J. Biol. Chem. 274 (1999) 35832-35839
51. Shipley J.M., Hurst C.H., Tanaka S.S., DeRoos F.L., Butenhoff J.L., Seacat A.M., and Waxman D.J. Trans-activation of PPARα and induction of PPARα target genes by perfluorooctane-based chemicals. Toxicol. Sci. 80 (2004) 151-160
52. Smithwick M., Norstrom R.J., Mabury S.A., Solomon K., Evans T.J., Stirling I., Taylor M.K., and Muir D.C. Temporal trends of perfluoroalkyl contaminants in polar bears (Ursus maritimus) from two locations in the North American Arctic, 1972-2002. Environ. Sci. Technol. 40 (2006) 1139-1143
53. Tabak H.F., Murk J.L., Braakman I., and Geuze H.J. Peroxisomes start their life in the endoplasmic reticulum. Traffic 4 (2003) 512-518
54. Takacs M.L., and Abbott B.D. Activation of mouse and human peroxisome prolixferator-activated receptors (α, β/δ, γ) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol. Sci. 95 (2006) 108-117
55. Vanden Heuvel J.P., Thompson J.T., Frame S.R., and Gillies P.J. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome prolixferator-activated receptor-α, -β and -γ, liver X receptor-β, and Retinoid X receptor-α. Toxicol. Sci. 92 (2006) 476-489
56. Willy P.J., Umesono K., Ong E.S., Evans R.M., Heyman R.A., and Mangelsdorf D.J. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9 (1995) 1033-1045
57. Yamamoto A., and Kawashima Y. Perfluorodecanoic acid enhances the formation of oleic acid in rat liver. Biochem. J. 325 (1997) 429-434
58. Yoshikawa T., Shimano H., Yahagi N., Ide T., Amemiya-Kudo M., Matsusuka T., Kakakuki M., Tomita S., Okazaki H., Tamura Y., Iizuka Y., Ohashi K., Takahashi A., Sone H., Osuga J.-I., Gotoda T., Ishibashi S., and Yamada N. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J. Biol. Chem. 277 (2002) 1705-1711